The center focuses on accelerating discoveries from bench to bedside and into the communities where better health is most needed. We unite laboratory science, clinical partnerships, and data-driven methods to transform rigorous research into practical tools: early diagnostics, prevention strategies, and equitable models of care.
Our work sits at the intersection of neurodegeneration and cardio-metabolic health, with a special focus on how mid-life cardiovascular risk shapes late-life brain outcomes. From blood-based biomarkers for Alzheimer’s and related dementias to real-world implementation studies, we design research that answers questions patients and clinicians face every day.
Our Mission
To reduce the global burden of neurodegenerative and cardiometabolic diseases by converting rigorous science into accessible tools—accurate diagnostics, targeted prevention, and equitable care.
Our Vision
A world where geography, income, and infrastructure no longer limit access to early detection and effective treatment.
MEET OUR TEAM
Dr. Thomas K. Karikari, Ph.D
EXECUTIVE DIRECTOR
Dr. Thomas Karikari, Ph.D., is an assistant professor of psychiatry at the Department of Psychiatry, University of Pittsburgh, U.S.A., and the Director of the Biofluid Biomarker Laboratory at the University of Pittsburgh, Director of Research Partnerships and Strategic alliances, Director of Mass Spectrometry Program, Univ. of Pittsburgh, Director, Single Molecule Analytics Program, Dept. of Psychiatry, Univ. of Pittsburgh, Director, University of Pittsburgh ADRC Neurogenetics and Biomarker Core and an Endowed Chair in peripheral biomarkers for brain diseases. Professor Karikari has extensive experience in establishing and managing clinical chemistry laboratories, developing and implementing standard operating procedures, and standardizing preanalytical protocols for the collection, measurement, and analysis of biospecimens, including cerebrospinal fluid (CSF) and blood. Prof. Karikari has been a board member and a consultant to several international bodies, such as Quanterix, SpearBio, American Society for Mass Spectrometry, ISTAART, etc.
Dr. Abdul Razak Monto, Ph.D.
DIRECTOR OF INTERNATIONAL OPERATIONS
Dr. Abdul Razak Monto, Ph.D., is a postdoctoral researcher in Clinical Neurochemistry at the Department of Psychiatry, University of Pittsburgh, U.S.A. With a strong background in biochemical and biological engineering, particularly biochemical and biomolecular analysis, with demonstrated expertise in analytical chemistry, gene expression, microbiological, biomedical research, and food chemistry analysis. Dr. Monto has experience in managing research laboratories, standardizing preanalytical procedures for sample collections, measurement, analysis, and developing and implementing standard operating protocols. A certified member of the Allied Health Professions Council of Ghana and ISTAART.
Dr.Amma Aboagyewa Larbi, PhD.
DIRECTOR OF ADMINISTRATION AND RESEARCH
Dr. Amma Larbi, Ph.D., is a senior lecturer at the Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Ghana. A member of professional bodies including: Ghana Science Association, Ghana Immunological Society, Organization for Women in Science for the Developing World, BioStruct-Africa, International Society for Infectious Diseases, and American Society of Microbiology. Dr. Larbi is an expert in immunology of infectious diseases, Neglected Tropical Diseases (NTDs), Host-pathogen interaction, Malaria genomics, and Autoimmune diseases.
Mr. Daniel Owusu-Adusei
DIRECTOR OF FINANCE
OUR TRUSTED PARTNERS
At CTBiomed, we don’t just research. We create experiences that inspire, engage, and leave a lasting impact.
